Scott M. Dehm

10.0k total citations · 2 hit papers
116 papers, 5.2k citations indexed

About

Scott M. Dehm is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Scott M. Dehm has authored 116 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pulmonary and Respiratory Medicine, 57 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Scott M. Dehm's work include Prostate Cancer Treatment and Research (91 papers), Ubiquitin and proteasome pathways (23 papers) and Hormonal and reproductive studies (19 papers). Scott M. Dehm is often cited by papers focused on Prostate Cancer Treatment and Research (91 papers), Ubiquitin and proteasome pathways (23 papers) and Hormonal and reproductive studies (19 papers). Scott M. Dehm collaborates with scholars based in United States, Canada and United Kingdom. Scott M. Dehm's co-authors include Donald J. Tindall, Yingming Li, Siu Chiu Chan, Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella, Kevin A.T. Silverstein, Keith Bonham, Tae Hyun Hwang and Lucas J. Brand and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Scott M. Dehm

105 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

2008 637 citations Scott M. Dehm, Lucy J. Schmidt et al. Cancer Research profile →
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines

2012 526 citations Yingming Li, Siu Chiu Chan et al. Cancer Research profile →

Peers

Countries citing papers authored by Scott M. Dehm

Since Specialization

Citations

This map shows the geographic impact of Scott M. Dehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Dehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Dehm more than expected).

Fields of papers citing papers by Scott M. Dehm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Dehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Dehm. The network helps show where Scott M. Dehm may publish in the future.

Co-authorship network of co-authors of Scott M. Dehm

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Dehm. A scholar is included among the top collaborators of Scott M. Dehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Dehm. Scott M. Dehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer 2025 ·Oncotarget ·(unknown), (unknown), (unknown), (unknown), Gaute Døhlen, (unknown), (unknown), (unknown), (unknown), Megan Ludwig, (unknown), (unknown), Hai Dang Nguyen, Scott M. Dehm, Justin M. Drake, Emmanuel S. Antonarakis, Justin H. Hwang	0
2	Evolving copy number gains promote tumor expansion and bolster mutational diversification 2024 ·Nature Communications ·(unknown), (unknown), (unknown), Αθανάσιος Ν. Νικολακόπουλος, (unknown), Scott M. Dehm, Jason M. Sheltzer, Ruping Sun	5
3	1648P Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI) 2024 ·Annals of Oncology ·Joshua M. Lang, (unknown), Susan F. Slovin, Jamie M. Sperger, Jennifer L. Schehr, (unknown), Alexandre Marcelo Hintz, Hamid Emamekhoo, Dana E. Rathkopf, Wassim Abida, K. Autio, (unknown), A. Mitchell, (unknown), Shuang G. Zhao, Jens C. Eickhoff, Scott M. Dehm, (unknown), Christos E. Kyriakopoulos	1
4	Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients 2024 ·Cancers ·(unknown), Megan Ludwig, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yingchun Zhao, Scott M. Dehm, Zuzan Caycı, Justin H. Hwang, Peter W. Villalta, Emmanuel S. Antonarakis, Justin M. Drake	0
5	Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling 2024 ·Science Advances ·(unknown), (unknown), (unknown), (unknown), Braedan M. McCluskey, (unknown), (unknown), (unknown), Scott Johnson, Kenneth Jacobsohn, Anjishnu Banerjee, Kenneth A. Iczkowski, Liang Wang, Scott M. Dehm, (unknown)	4
6	Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling 2023 ·Proceedings of the National Academy of Sciences ·(unknown), Adam M. Lee, (unknown), Yingbo Huang, Yeung Ho, (unknown), (unknown), (unknown), (unknown), Alexander Ling, Ying-Ming Li, Scott M. Dehm, R. Stephanie Huang	11
7	Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment 2022 ·Molecular Cancer Research ·Hugues Sicotte, Krishna R. Kalari, Sisi Qin, Scott M. Dehm, Vipul Bhargava, Michael Gormley, Winston Tan, Jason P. Sinnwell, David W. Hillman, (unknown), Peter T. Vedell, Rachel E. Carlson, Alan H. Bryce, (unknown), Richard M. Weinshilboum, Manish Kohli, Liewei Wang	9
8	Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer 2020 ·Clinical Cancer Research ·Yingming Li, Rendong Yang, Christine Henzler, Yeung Ho, Courtney N. Passow, Benjamin Auch, Suzanne Carreira, Daniel Nava Rodrigues, Cláudia Bertan, Tae Hyun Hwang, David A. Quigley, Ha X. Dang, Colm Morrissey, Michael Fraser, Stephen R. Plymate, Christopher A. Maher, Felix Y. Feng, Johann S. de Bono, Scott M. Dehm	62
9	PEG10 Promoter–Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer 2019 ·Cancer Research ·(unknown), John K. Lee, Yingming Li, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Scott M. Dehm, Aaron M. LeBeau	12
10	Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer 2019 ·Clinical Cancer Research ·Paige M. Glumac, (unknown), (unknown), Yingming Li, Paari Murugan, Shilpa Gupta, Ilsa M. Coleman, Peter S. Nelson, Scott M. Dehm, Aaron M. LeBeau	17
11	Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions 2017 ·Molecular Cancer Therapeutics ·Kush Dalal, Meixia Che, (unknown), Aishwariya Sharma, Rendong Yang, Nada Lallous, Hendrik Borgmann, (unknown), (unknown), Fuqiang Ban, Huifang Li, Kevin J. Tam, Mani Roshan‐Moniri, Eric Leblanc, Martin Gleave, D.T. Gewirth, Scott M. Dehm, Artem Cherkasov, Paul S. Rennie	27
12	Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer 2017 ·Cancer Research ·Jamie L. Van Etten, Michael D. Nyquist, Yingming Li, Rendong Yang, Yeung Ho, Rachel K. Johnson, (unknown), Daniel F. Voytas, Christine Henzler, Scott M. Dehm	51
13	Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation 2016 ·Clinical Cancer Research ·Jamie M. Sperger, (unknown), Allison W. Welsh, Benjamin P. Casavant, (unknown), (unknown), Erika Héninger, (unknown), (unknown), (unknown), David J. Guckenberger, Lakeesha Carmichael, Scott M. Dehm, Philip J. Stephens, David J. Beebe, Scott M. Berry, Joshua M. Lang	50
14	Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines breakdown → 2012 ·Cancer Research ·Yingming Li, Siu Chiu Chan, Lucas J. Brand, Tae Hyun Hwang, Kevin A.T. Silverstein, Scott M. Dehm	526
15	Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression 2011 ·Cancer Research ·Yingming Li, (unknown), Danhua Fan, G. Steven Bova, Ahmed H. Tewfik, Scott M. Dehm	160
16	Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81 2009 ·Cancer Research ·Sook Shin, Tae‐Dong Kim, Fang Jin, Jan M. van Deursen, Scott M. Dehm, Donald J. Tindall, Joseph P. Grande, (unknown), George Vasmatzis, Ralf Janknecht	67
17	Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance breakdown → 2008 ·Cancer Research ·Scott M. Dehm, Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella, Donald J. Tindall	637
18	Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells 2007 ·Cancer Research ·Scott M. Dehm, Kevin M. Regan, Lucy J. Schmidt, Donald J. Tindall	64
19	Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer 2007 ·Cancer Research ·Hannelore V. Heemers, Kevin M. Regan, Scott M. Dehm, Donald J. Tindall	53
20	p300 Regulates Androgen Receptor–Independent Expression of Prostate-Specific Antigen in Prostate Cancer Cells Treated Chronically with Interleukin-6 2005 ·Cancer Research ·José D. Debes, Barbara Comuzzi, Lucy J. Schmidt, Scott M. Dehm, Zoran Čulig, Donald J. Tindall	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact